CRBU
Price
$1.86
Change
-$0.04 (-2.11%)
Updated
Dec 11 closing price
Capitalization
173.85M
94 days until earnings call
Intraday BUY SELL Signals
FATE
Price
$1.16
Change
+$0.04 (+3.60%)
Updated
Dec 12, 04:59 PM (EDT)
Capitalization
128.04M
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs FATE

Header iconCRBU vs FATE Comparison
Open Charts CRBU vs FATEBanner chart's image
Caribou Biosciences
Price$1.86
Change-$0.04 (-2.11%)
Volume$1.06M
Capitalization173.85M
Fate Therapeutics
Price$1.16
Change+$0.04 (+3.60%)
Volume$36.6K
Capitalization128.04M
CRBU vs FATE Comparison Chart in %
CRBU
Daily Signal:
Gain/Loss:
FATE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBU vs. FATE commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FATE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (CRBU: $1.86 vs. FATE: $1.11)
Brand notoriety: CRBU and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 39% vs. FATE: 53%
Market capitalization -- CRBU: $173.85M vs. FATE: $128.04M
CRBU [@Biotechnology] is valued at $173.85M. FATE’s [@Biotechnology] market capitalization is $128.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while FATE’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 6 bearish.
  • FATE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FATE is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -4.12% price change this week, while FATE (@Biotechnology) price change was +0.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

FATE is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($174M) has a higher market cap than FATE($128M). CRBU YTD gains are higher at: 16.981 vs. FATE (-32.727). CRBU has higher annual earnings (EBITDA): -150.76M vs. FATE (-161.6M). FATE has more cash in the bank: 223M vs. CRBU (184M). CRBU has less debt than FATE: CRBU (25.9M) vs FATE (81.3M). CRBU has higher revenues than FATE: CRBU (9.12M) vs FATE (8.47M).
CRBUFATECRBU / FATE
Capitalization174M128M136%
EBITDA-150.76M-161.6M93%
Gain YTD16.981-32.727-52%
P/E RatioN/AN/A-
Revenue9.12M8.47M108%
Total Cash184M223M83%
Total Debt25.9M81.3M32%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFATE
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
FATE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GVYB22.00N/A
N/A
Golden Valley Bancshares, Inc.
RSHPF1.09N/A
N/A
Irish Residential Properties REIT PLC
RUBSF35.58N/A
N/A
RUBIS
NEXOY24.68-0.14
-0.56%
Nexon Co Ltd.
DRCR0.05N/A
-0.95%
Dear Cashmere Holding Co.